Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06602973 · ClinicalTrials.gov registry record · NA
Relationships Between Exercise and Appetite in Women With Loss of Control Eating
A NA study of Binge-Eating Disorder and Eating Disorders, sponsored by Ohio University.
- Recruiting
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT06602973: Recruiting NA study of Binge-Eating Disorder and Eating Disorders, sponsored by Ohio University.
NCT06602973 is a NA study of Binge-Eating Disorder and Eating Disorders that is actively recruiting participants, run by Ohio University. The registered enrollment target is 26 participants, below the 1,143-participant average among 37 other Binge-Eating Disorder trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06602973, a NA study of Binge-Eating Disorder and Eating Disorders, is actively recruiting participants, sponsored by Ohio University.
- RECRUITING
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot study is a first step in looking at the relationship between exercise and appetite in women with loss of control eating.
Primary Outcome
Relative energy intake for 24 hours will be calculated as absolute energy intake from the breakfast (if consumed), lunch, food reward value task, and take home cooler minus energy expenditure during exercise (or comparable time period during rest).
Conditions Studied
Interventions
- BEHAVIORAL Rest
- BEHAVIORAL Fed Exercise
- BEHAVIORAL Fasted Exercise
Study Locations (1)
Ohio
- Ohio University - Athens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2024-08-30 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT06602973 shows while recruiting
NCT06602973 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,143-participant average among 37 other Binge-Eating Disorder trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Binge-Eating Disorder appearing as the primary indexed condition, and to 3 interventions - of which Rest is the first listed.
NCT06602973 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06602973 about?
NCT06602973 is a clinical study titled "Relationships Between Exercise and Appetite in Women With Loss of Control Eating". This pilot study is a first step in looking at the relationship between exercise and appetite in women with loss of control eating.
What is the current status of trial NCT06602973?
This trial is currently recruiting. It is a NA study. The enrollment target is 26 participants. The study started on 2024-08-30. Estimated completion is 2026-08.
What conditions does trial NCT06602973 study?
This clinical trial studies the following conditions: Binge-Eating Disorder, Eating Disorders, Bulimia Nervosa.
What interventions are being tested in trial NCT06602973?
The interventions under investigation include: Rest (BEHAVIORAL), Fed Exercise (BEHAVIORAL), Fasted Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT06602973?
This trial is sponsored by Ohio University, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06602973 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Binge-Eating Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06602973's enrollment target sits among peer trials
26 32nd of 37 higher than 6 of 37 other Binge-Eating Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Binge-Eating Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Use of Circadian Reset Technology to Alter REM Sleep and Appetitive Control in Patients With Binge Eating Disorder
RECRUITING · NA
-
Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders
RECRUITING · NA
-
Treating Binge Eating and Obesity Digitally in Black Women
RECRUITING · NA
-
Preventing Type 2 Diabetes in Black Emergent Adult
RECRUITING · NA
-
Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes
RECRUITING · NA
-
Building an Equitable and Accessible System of Eating Disorder Care for VA, DoD, and Underrepresented Americans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI